Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant in Autologous HSCT
NCT02576327Phase 4Unknown
- Start
- Oct 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV). Status: unknown.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02576327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576327.